Logo

American Heart Association

  42
  0


Final ID:

Will advanced technology therapies be available to everyone?

  • Taylor, Casey  ( Johns Hopkins School of Medicine , Baltimore , Maryland , United States )
  • Longhurst, Christopher  ( UCSD , San Diego , California , United States )
  • Rodriguez, Fatima  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Farr, Maryjane  ( University of Texas Southwestern , Dallas , Texas , United States )
  • Author Disclosures:
    Casey Taylor: No Answer | Christopher Longhurst: No Answer | Fatima Rodriguez: DO have relevant financial relationships ; Consultant:HealthPals:Past (completed) ; Consultant:Cleerly Health:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:iRhythm:Active (exists now) ; Consultant:HeartFlow:Active (exists now) ; Consultant:Arrowhead Pharmaceuticals:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Inclusive Health:Active (exists now) ; Consultant:Esperion Therapeutics:Past (completed) ; Consultant:Kento Health:Active (exists now) ; Consultant:Movano Health:Active (exists now) ; Consultant:NovoNordisk:Past (completed) ; Consultant:Novartis:Active (exists now) | Maryjane Farr: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Bionic Humans: Understanding and Treating Cardiovascular Diseases in Human-device Hybrids

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available